Genpact executive Piyush Mehta sells 200,000 shares

Q: How many Genpact (G) shares did Piyush Mehta sell, and at what price?

Piyush Mehta sold 200,000 common shares on November 10, 2026, at a weighted average price of $43.045 per share. The reported sale prices ranged from $42.85 to $43.215 per share.

Q: What options did Genpact (G) executive Piyush Mehta exercise?

Mehta exercised options covering 200,000 common shares on November 10, 2026, at an exercise price of $27.70 per share; the transaction reports 200,000 common shares acquired.

Q: How many Genpact shares does Piyush Mehta hold under the ESPP?

Mehta’s footnote states that he currently holds 10,850 shares under Genpact’s Employee Stock Purchase Plan. It also says he acquired 338 ESPP shares since his Form 4 filed on March 12, 2026.

Available on EDGAR 11/13/2026 - 04:25 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:25 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Genpact Ltd. Senior Vice President and CHRO Piyush Mehta exercised options for 200,000 common shares on November 10, 2026, at an exercise price of $27.70 per share, then sold 200,000 common shares that day at a weighted average price of $43.045 per share.

The reported sale prices ranged from $42.85 to $43.215 per share. Mehta’s footnote says he acquired 338 shares under Genpact’s Employee Stock Purchase Plan since his Form 4 filed on March 12, 2026, and currently holds 10,850 shares under that plan. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 200,000 shares ($3.07M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Mehta Piyush

Role Senior Vice President and CHRO

Sold 200,000 shs ($8.61M)

Approx. gross sale proceeds $8.61M

Approx. exercise cost $5.54M

Approx. pre-tax spread $3.07M

Share of Position Sold 56.1%

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy) ^F3	200,000	$0.00	$0.00
Exercise	Common Shares ^F1	200,000	$27.70	$5.54M
Sale	Common Shares ^F2	200,000	$43.045	$8.61M

Holdings After Transaction: Employee Stock Option (Right to Buy) — 76,167 options (Direct); Common Shares — 156,823 shares (Direct)

Holdings Before and After: Employee Stock Option (Right to Buy), 276,167 to 76,167 options (Direct); Common Shares, 156,823 to 156,823 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (3)

F1. Includes 338 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on March 12, 2026. The reporting person currently holds a total of 10,850 shares under the ESPP.
F2. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.85 to $43.215. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3. The option vested 50% on January 10, 2022 and the remainder on January 10, 2024.

Key Figures

Options exercised: 200,000 options covering common shares Exercise price: $27.70 per share Common shares acquired: 200,000 shares +5 more

8 metrics

Options exercised 200,000 options covering common shares November 10, 2026

Exercise price $27.70 per share Options exercised November 10, 2026

Common shares acquired 200,000 shares Upon option exercise on November 10, 2026

Common shares sold 200,000 shares November 10, 2026

Weighted average sale price $43.045 per share Sale on November 10, 2026

Sale price range $42.85 to $43.215 per share Reported range for the November 10, 2026 sale

ESPP shares currently held 10,850 shares As stated in the footnote

ESPP shares acquired 338 shares Since the Form 4 filed on March 12, 2026

Key Terms

Employee Stock Purchase Plan (ESPP), weighted average price

2 terms

Employee Stock Purchase Plan (ESPP) financial

"shares acquired under the Genpact Employee Stock Purchase Plan (ESPP)"

weighted average price financial

"The price in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Genpact (G) shares did Piyush Mehta sell, and at what price?

Piyush Mehta sold 200,000 common shares on November 10, 2026, at a weighted average price of $43.045 per share. The reported sale prices ranged from $42.85 to $43.215 per share.

What options did Genpact (G) executive Piyush Mehta exercise?

Mehta exercised options covering 200,000 common shares on November 10, 2026, at an exercise price of $27.70 per share; the transaction reports 200,000 common shares acquired.

How many Genpact shares does Piyush Mehta hold under the ESPP?

Mehta’s footnote states that he currently holds 10,850 shares under Genpact’s Employee Stock Purchase Plan. It also says he acquired 338 ESPP shares since his Form 4 filed on March 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mehta Piyush

(Last)

(First)

(Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK

10175

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior Vice President and CHRO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	11/10/2026		M		200,000	A	$27.7	356,823⁽¹⁾	D
Common Shares	11/10/2026		S		200,000	D	$43.045⁽²⁾	156,823	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$27.7	11/10/2026		M			200,000	⁽³⁾	01/09/2029	Common Shares	200,000	$0	76,167	D

Explanation of Responses:

1. Includes 338 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on March 12, 2026. The reporting person currently holds a total of 10,850 shares under the ESPP.

2. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.85 to $43.215. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

3. The option vested 50% on January 10, 2022 and the remainder on January 10, 2024.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Brian Lamb, as Attorney-in-fact for Piyush Mehta	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR